Clinical Trials

    Showing 1 - 7 of 7 Bincy Abraham

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

    Status: Open Not Enrolling

    Investigator: Bincy Abraham

    Study Coordinator:

    Phone:

    This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.... Read more >

    A randomized, double-blind, placebo controlled, dosefinding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis

    Status: Enrolling

    Investigator: Bincy Abraham

    Study Coordinator: Melissa Whipple

    Phone: 713.441.3247

    This is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for further c... Read more >

    ABTECT - Maintenance

    Status: Open Not Enrolling

    Investigator: Bincy Abraham

    Study Coordinator: Melissa Whipple

    Phone: 713.441.3247

    This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate re... Read more >

    ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

    Status: Open Not Enrolling

    Investigator: Bincy Abraham

    Study Coordinator: Melissa Whipple

    Phone: 713.441.3247

    This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate res... Read more >

    Corrona Inflammatory Bowel Disease (IBD) Registry

    Status: Enrolling

    Investigator: Bincy Abraham

    Study Coordinator:

    Phone:

    This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary o... Read more >

    Effi cacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease (ENHANCE-CD)

    Status: Enrolling

    Investigator: Bincy Abraham

    Study Coordinator: Melissa Whipple

    Phone: 713.441.3247

    This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared to placebo as induction and maintenance therapy... Read more >

    VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

    Status: Enrolling

    Investigator: Bincy Abraham

    Study Coordinator: Melissa Whipple

    Phone: 713.441.3247

    Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational studies suggest that TMH may be associated with better long-term outcomes. The study will evaluate TMH u... Read more >